Immunosuppression in irradiated breast cancer patients: In vitro effect of cyclooxygenase inhibitors
We have documented in previous studies that local irradiation therapy for breast cancer caused severe lymphopenia with reduction of both T and non-T lymphocytes. Non-T cells were relatively more depressed but recovered within six months. The recovery of T cells, on the other hand, remained incomplete 10-11 years after irradiation. Several lymphocyte functions were also severely impaired. An association was found between prognosis and postirradiation mitogen reactivity of lymphocytes from these patients. Mortality up to eight years after irradiation was significantly higher in patients with low postirradiation phytohemagglutinin and PPD reactivity. The radiation induced decrease in mitogenic response seemed mainly to be caused by immunosuppressive monocytes, which suggests that the underlying mechanism might be mediated by increased production of prostaglandins by monocytes. For this reason we examined the effect of some cyclooxygenase products on different lymphocyte functions and found that prostaglandins A2, D2, and E2 inhibited phytohemagglutinin response in vitro. Natural killer cell activity was also reduced by prostaglandins D2 and E2. The next step was to examine various inhibitors of cyclooxygenase in respect to their capacity to revert irradiation-induced suppression of in vitro mitogen response in lymphocytes from breast cancer patients. It was demonstrated that Diclofenac Na (Voltaren), Meclofenamic acid, Indomethacin, and lysin-mono-acetylsalicylate (Aspisol) could enhance mitogen responses both before and after radiation therapy. This effect was most pronounced at completion of irradiation. On a molar basis, Diclofenac Na was most effective followed by Indomethacin, Meclofenamic acid, and lysin-monoacetylsalicylate.
- OSTI ID:
- 7104939
- Journal Information:
- Bulletin of the New York Academy of Medicine; (USA), Vol. 65:1; ISSN 0028-7091
- Country of Publication:
- United States
- Language:
- English
Similar Records
Lymphoid irradiation in intractable rheumatoid arthritis. Long-term followup of patients treated with 750 rads or 2,000 rads
Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms
Related Subjects
ENZYME INHIBITORS
RADIOSENSITIVITY EFFECTS
MAMMARY GLANDS
NEOPLASMS
RADIOTHERAPY
PROSTAGLANDINS
BIOLOGICAL FUNCTIONS
SIDE EFFECTS
BIOLOGICAL RECOVERY
DELAYED RADIATION EFFECTS
IMMUNOSUPPRESSION
IN VITRO
LYMPHOCYTES
MONOCYTES
PATIENTS
ANIMAL CELLS
BIOLOGICAL EFFECTS
BIOLOGICAL MATERIALS
BIOLOGICAL RADIATION EFFECTS
BLOOD
BLOOD CELLS
BODY
BODY FLUIDS
CONNECTIVE TISSUE CELLS
DISEASES
FUNCTIONS
GLANDS
LEUKOCYTES
MATERIALS
MEDICINE
NUCLEAR MEDICINE
ORGANS
RADIATION EFFECTS
RADIOLOGY
RECOVERY
SOMATIC CELLS
THERAPY
560151* - Radiation Effects on Animals- Man